Robert J. Bertolini's most recent trade in Charles River Laboratories International Inc. was a trade of 1,311 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on May 13, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Charles River Laboratories... | Robert J. Bertolini | Director | 13 May 2024 | 1,311 | 1,311 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories... | Robert J. Bertolini | Director | 13 May 2024 | 559 | 32,408 (0%) | 0% | 228.4 | 127,681 | Common Stock | |
| Charles River Laboratories... | Robert J. Bertolini | Director | 13 May 2024 | 394 | 32,802 (0%) | 0% | 228.4 | 89,994 | Common Stock | |
| Charles River Laboratories... | Robert J. Bertolini | Director | 15 May 2023 | 1,669 | 1,669 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories... | Robert J. Bertolini | Director | 15 May 2023 | 664 | 31,381 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | Robert J. Bertolini | Director | 15 May 2023 | 468 | 31,849 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | Robert J. Bertolini | Director | 11 May 2022 | 1,582 | 1,582 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories... | Robert J. Bertolini | Director | 11 May 2022 | 575 | 30,312 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | Robert J. Bertolini | Director | 11 May 2022 | 405 | 30,717 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | Robert J. Bertolini | Director | 07 May 2021 | 1,151 | 1,151 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories... | Robert J. Bertolini | Director | 07 May 2021 | 355 | 29,489 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | Robert J. Bertolini | Director | 07 May 2021 | 248 | 29,737 (0%) | 0% | 0 | Common Stock | ||
| Bristol-Myers Squibb Co. | Robert J. Bertolini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 554 | 26,648 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Robert J. Bertolini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 3,054 | 26,094 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Robert J. Bertolini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2020 | 564 | 22,859 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Robert J. Bertolini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 580 | 22,128 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Robert J. Bertolini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 595 | 21,384 | - | - | Deferred Share Units |